clinical trial · NCT05665699
Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout
InventisBio Co., Ltd·phase2·active not recruiting·n = 80
GoutD-0120Allopurinol
brief summary
D-0120 is being tested in combination with Allopurinol in adult subjects with Gout.
started
Apr 17, 2023
primary completion
Jul 31, 2025
completion
Dec 30, 2025
last updated
May 8, 2025
official title
A Randomized, Open-Label, Multiple-Dose Phase II Study to Evaluate Efficacy and Safety of D-0120 Administered in Combination With Allopurinol in Subjects With Gout
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol